share_log

Enlivex Therapeutics | 424B3: Prospectus

SEC ·  Jul 10, 2019 08:18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more